Contact Us 1-877-743-4652
Click to toggle navigation menu.

Philadelphia Mesothelioma Lawyers Report BAP1 Gene Mutation Increases Survival Rates for Mesothelioma Patients

Philadelphia Mesothelioma Lawyers Report BAP1 Gene Mutation Increases Survival Rates for Mesothelioma Patients

Philadelphia Mesothelioma Lawyers Report BAP1 Gene Mutation Increases Survival Rates for Mesothelioma Patients

January 5, 2015 – In a recent study published in Carcinogenesis, researchers have concluded that the BAP1 gene mutation found in patients with mesothelioma may prove to prolong the survival rates of those with the terminal illness.  The study included the analysis of 37 years of data from over 10,000 mesothelioma patients in the US […]

Read More
Philadelphia Mesothelioma Lawyers Report: Study Reveals Eligible Mesothelioma Patients Not Receiving Chemotherapy

Philadelphia Mesothelioma Lawyers Report: Study Reveals Eligible Mesothelioma Patients Not Receiving Chemotherapy

December 29, 2014 –  A new Australian research study shows that many mesothelioma patients may not be getting all of the treatment options that are available.  Researchers from the Asbestos Disease Research Institute and Sydney Medical School analyzed data from a multinational group of patients to see if optimal treatment methods match what is being […]

Read More
Philadelphia Mesothelioma Lawyers:  Underreporting of Mesothelioma Cases

Philadelphia Mesothelioma Lawyers:  Underreporting of Mesothelioma Cases

December 22, 2014 – While scientists work to find better treatment strategies for mesothelioma, reporting of the actual number of cases is crucial to their research. A new study has recently found that in many countries such as Spain, the incidence of mesothelioma remains significantly underreported.  According to a study conducted by Spain’s Ministry of […]

Read More
Philadelphia Asbestos Lawyers Discuss Immunotherapy as a Treatment Option for Mesothelioma

Philadelphia Asbestos Lawyers Discuss Immunotherapy as a Treatment Option for Mesothelioma

December 15, 2014 – There may soon be a new treatment option available for patients suffering with mesothelioma.  Initial research indicates that immunotherapy treatment may be effective for those suffering from malignant mesothelioma. Exposure to asbestos causes malignant mesothelioma with solid tumors typically forming in the pleural lining of the lungs.  Until recently, treatment options […]

Read More
Study Reveals Link between Carbon Nanotubes and Mesothelioma

Study Reveals Link between Carbon Nanotubes and Mesothelioma

December 8, 2014 – A new study published in the journal Particle and Fibre Toxicology uncovers the risk of developing mesothelioma at the hands of exposure to a hazardous synthetic material used in many electronics and textile manufacturing.  The artificial material is molecules comprised of multi-walled carbon nanotubes (MWCNTs) that contain carbon and are molded into […]

Read More
Philadelphia Mesothelioma Lawyers: Philadelphia Hospital is First to Participate in Worldwide Photofrin Trial

Philadelphia Mesothelioma Lawyers: Philadelphia Hospital is First to Participate in Worldwide Photofrin Trial

November 14, 2014 – Thomas Jefferson University Hospital in Philadelphia has been designated as one of several worldwide Phase 3 trial sites to study the effectiveness of a new drug that may help in the fight against mesothelioma.  Photofrin, a drug developed by Pinnacle Biologics is currently being used to combat rare cancers of the […]

Read More
Philadelphia Asbestos Lawyers Report on Encouraging Mesothelioma Orphan Drug Trial Results

Philadelphia Asbestos Lawyers Report on Encouraging Mesothelioma Orphan Drug Trial Results

November 10, 2014 – The experimental drug amatuximab has shown promising results in treating pleural mesothelioma patients.  Researchers at the National Cancer Institute reported that the addition of amatuximab to traditional mesothelioma chemotherapy stopped mesothelioma tumor growth or shrank tumors in 90% of patients participating in a Phase II trial of this orphan drug.  Amatuximab […]

Read More
Philadelphia Asbestos Lawyers Discuss Recent Research Findings that Could Improve Mesothelioma Treatment

Philadelphia Asbestos Lawyers Discuss Recent Research Findings that Could Improve Mesothelioma Treatment

November 3, 2014 – Mesothelioma is notorious for poor patient prognosis and limited treatment options which heavily lowers life expectancy. However, researchers may now be one step closer to effective treatment due in part to curcumin which is a component of the common spice turmeric. Curcumin is known to have anti-inflammatory and cancer- inhibiting properties. […]

Read More
Click for live chat!